Cargando…
Neuropeptide Y mediates cardiac hypertrophy through microRNA-216b/FoxO4 signaling pathway
Cardiac hypertrophy (CH) is a major risk factor for heart failure accompanied by maladaptive cardiac remodeling. The role and potential mechanism of neuropeptide Y (NPY) in CH are still unclear. We will explore the role and the mechanism of NPY inactivation (NPY-I) in CH caused by pressure overload....
Autores principales: | Wang, Jinghao, Hao, Dan, Zeng, Lingfeng, Zhang, Qianhui, Huang, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738963/ https://www.ncbi.nlm.nih.gov/pubmed/33390770 http://dx.doi.org/10.7150/ijms.51133 |
Ejemplares similares
-
The role and molecular mechanism of FoxO1 in mediating cardiac hypertrophy
por: Yu, Wei, et al.
Publicado: (2020) -
Galanin promotes autophagy and alleviates apoptosis in the hypertrophied heart through FoxO1 pathway
por: Martinelli, Ilenia, et al.
Publicado: (2021) -
Association Study to Evaluate FoxO1 and FoxO3 Gene in CHD in Han Chinese
por: Zhao, Ying, et al.
Publicado: (2014) -
MicroRNA-124-5p delays the progression of cerebral aneurysm by regulating FoxO1
por: Wang, Ru-Ke, et al.
Publicado: (2021) -
FoxO Proteins in the Nervous System
por: Maiese, Kenneth
Publicado: (2015)